Wave Life Sciences (WVE) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

External links

Employees

Data from SEC filings

Employee count

CEO pay ratio

CEO Salary

Median Employee Salary

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Contaminant Coral Environment Environmental Escape Extraction Green Intensity Life Cycle Materials Nature Nuclear Offset Package Packaging Pandemic Raw Materials Recycle Recycling Regenerative Toxic Waste Access African American Asian Benefits Black California Consumer Privacy Act Charity Citizenship Collective Bargaining Community Community Engagement Culture Customer Cyber Cyber Security Cybersecurity Data Privacy Death Disability Diversity Drug Pricing Employee Employee Engagement Engagement Ethnic Ethnicity Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Hispanic Human Capital Human Resources Incident Injuries Injury Latinx Minority Pay Equity Privacy Product Quality Product Safety Recall Recruit Recruitment Reimbursement Retention Retirement Safety Satisfaction Skill Skills Social Society Stakeholder Supplier Supply Chain Talent Training Union Volunteer Women Workers Workforce Workplace Safety Action Plan Assessment Assurance Attorney General Audit Bonus Bribery Chronic Classified Clawback Commitment Conflict of Interest Corporate Governance Corruption Department of ESG Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Independence Independent Innovate Innovation Innovative Investigation Lawsuit Leadership Litigation Long-term Majority Materiality Mission Oversee Oversight Pledging Procurement Purpose Quality Standard R&D Reputation Reputational Reputational Risk Research and Development Responsibility Responsible Shareholder Proposals Stewardship Strategy Sustainability Sustainable Targets Tax Tenure Transparency Transparent Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

(a)

On August 9, 2022, the Company held its 2022 Annual General Meeting of Shareholders (the “Annual Meeting”). Of the 86,820,111 ordinary shares issued and outstanding and eligible to vote as of the meeting date of August 9, 2022, a quorum of 74,350,854 ordinary shares, or 85.6%, of the eligible shares, was present in person or represented by proxy at the Annual Meeting.

(b)	The following actions were taken at the Annual Meeting, all of which are described in the Proxy Statement. The final voting results for each of the proposals voted upon at the Annual Meeting are set forth below.

Proposal 1 (a) – (i)- Shareholders re-elected nine of the Company’s existing directors to the Board of Directors for a term ending on the Company’s 2023 Annual General Meeting of Shareholders and his or her successor is duly elected and qualified, with the final votes cast as follows:

Board of Directors Nominee				Broker Non-Vote

Paul B. Bolno, M.D., MBA	64,917,424	75,764	5,749	9,351,917
Mark H.N. Corrigan, M.D.	64,873,315	117,858	7,764	9,351,917
Christian Henry	62,407,390	2,576,993	14,554	9,351,917
Peter Kolchinsky, Ph.D.	52,452,041	12,532,947	13,949	9,351,917
Adrian Rawcliffe	63,604,235	1,385,540	9,162	9,351,917
Ken Takanashi	63,341,573	1,609,840	47,524	9,351,917
Aik Na Tan	64,871,533	74,473	52,931	9,351,917
Gregory L. Verdine, Ph.D.	64,920,357	73,584	4,996	9,351,917
Heidi L. Wagner, J.D.	63,558,481	1,425,598	14,858	9,351,917

Proposal 2- Shareholders re-appointed KPMG LLP to serve as the Company’s independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2022, and to authorize the Audit Committee of the Board of Directors to fix KPMG LLP’s remuneration for services provided through the date of the Company’s 2023 Annual General Meeting of Shareholders, with the final votes cast as follows:

For		Against		Abstain		Broker Non-Vote

74,324,836		11,072		14,946		0

Proposal 3- Shareholders approved the Company’s payment of cash and equity-based compensation to the Company’s non-employee directors for their service on the Board of Directors and its committees, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast as follows:

For		Against		Abstain		Broker Non-Vote

64,862,136		124,798		12,003		9,351,917

Proposal 4- Shareholders approved the amendment to the Company’s 2021 Equity Incentive Plan, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast as follows:

For		Against		Abstain		Broker Non-Vote

64,823,982		152,596		22,359		9,351,917

Proposal 5- Shareholders approved a general authorization for the directors of the Company to allot and issue ordinary shares of the Company, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast as follows:

For		Against		Abstain		Broker Non-Vote

64,848,102		133,598		17,237		9,351,917

Proposal 6- Shareholders approved on a non-binding, advisory basis only, the compensation of our named executive officers, in the manner and on the basis set forth described in the proxy statement, with the final votes cast as follows:

For		Against		Abstain		Broker Non-Vote

51,160,648		13,821,016		17,273		9,351,917